A New Perspective on Cell Quality
Cell quality is one of the most important determinants of success across advanced biologics and ATMP development — yet most analytics still rely on a single, binary question: are the cells alive or dead? Traditional viability assays provide a snapshot of the current state, but they reveal nothing about the functional strength, resilience, or metabolic readiness of those cells. A culture can be “viable” on paper while still being too weak, stressed, or damaged to support reliable or lengthy manufacturing processes.
Subtle differences in cell fitness become especially consequential in cell therapy, gene therapy, and vaccine development, where small functional shifts can reshape how cells grow and behave — from expansion potential and activation to differentiation and transduction efficiency. These changes ultimately influence vector productivity and overall process performance.
Viability alone cannot capture these functional attributes — it cannot predict whether cells will remain robust over the next 24 hours, let alone whether they can sustain an entire bioprocess.
Radiance® changes this paradigm. Built on Laser Force Cytology™ (LFC), Radiance® delivers label‑free, single‑cell measurements that quantify intrinsic biochemical and biophysical properties tied directly to cell vitality. These real‑time insights provide a holistic view of cell quality, revealing not just whether cells are alive, but whether they are strong enough to thrive and deliver effective therapeutic outcomes.
With a 5‑minute time‑to‑result and 10-minute sample preparation, Radiance® gives teams the clarity and speed needed to make confident decisions at critical points — from donor selection and cell bank qualification to upstream optimization and ATMP manufacturing.
Why Vitality Matters More Than Viability
Viability tells you whether a cell is alive or dead — nothing more. It is a binary, present‑state measurement, and while useful, it offers no insight into whether those “viable” cells are actually capable of supporting an advanced biologic or ATMP workflow. A culture can show high viability yet still be metabolically exhausted, structurally compromised, or functionally weak.
Vitality, by contrast, reflects the true fitness and resilience of a cell population. It captures how well cells can withstand stress, recover from thaw, expand, transduce, or produce vectors — all of which directly influence outcomes in cell therapy, gene therapy, vaccine development, and other advanced biologics manufacturing.
Across these modalities, vitality has emerged as a far stronger predictor of downstream success than viability alone. Subtle differences in vitality can determine:
- Expansion potential of donor‑derived cells
- Potency stability across scale‑up
- Productivity durability in vector‑producing cells
- Stress resilience in vaccine production cells
- Yield optimization in ATMP manufacturing
Vitality at thaw is a decisive inflection point. The functional state of cells in these first moments strongly predicts final product quality, batch‑to‑batch consistency, and overall manufacturing success. Teams that rely on viability alone risk advancing material that looks acceptable on paper but is functionally unprepared for the demands of modern bioprocessing.
Radiance® closes this gap with quantitative, single‑cell vitality measurements that expose the true health and functional potential of a cell population. These whole‑cell signatures reveal early warning signs and performance‑limiting weaknesses long before traditional assays detect a problem, giving developers the confidence to act sooner and protect downstream outcomes.
How Radiance® Measures Holistic Cell Quality
Radiance® uses Laser Force Cytology™ with LumaCyte’s proprietary optical and fluidic force measurements to quantify intrinsic biochemical and biophysical properties that directly reflect cell vitality. Because LFC measures the whole cell in its native state — without dyes, stains, or manipulation — it captures functional integrity that viability assays cannot.
This whole‑cell sensitivity allows Radiance® to detect phenotypic changes and rapidly quantify early indicators of cellular response to viral infection, activation, transfection, and differentiation. These early functional signatures reveal whether cells are truly prepared for expansion, transduction, or downstream manufacturing — not just alive in the moment.
The result is a far more predictive readout of cellular fitness, giving teams the confidence to qualify starting material based on real functional potential rather than limited viability snapshots.
These capabilities make Radiance® a powerful tool for evaluating cell quality across gene therapy vector production, cell therapy expansion workflows, vaccine manufacturing, and other advanced biologics processes where cell fitness directly impacts yield and consistency.
Predictive Modeling for Cell Vitality & Viability
Radiance® measures intrinsic, whole‑cell properties tied directly to functional performance, enabling predictive modeling that extends far beyond traditional viability checks. Early vitality signatures can forecast whether cells will:
- Survive and recover after thaw
- Expand to target densities
- Maintain potency through culture
- Sustain vector production
- Withstand bioprocess stress
These predictions give teams a meaningful head start. Instead of discovering problems mid‑process, developers can identify at‑risk donors, lots, or cell banks before they enter production — reducing failure rates, improving batch‑to‑batch consistency, and strengthening overall process reliability.
Radiance® shifts vitality analytics from a retrospective snapshot to a forward‑looking quality strategy for advanced biologics and ATMP manufacturing.
Predictive Cell Function at Thaw
Thaw is one of the most consequential decision points in any cell‑based workflow. The functional state of cells at this moment is highly predictive of downstream success — yet most teams still rely on viability alone to make go/no‑go calls.
Radiance® provides a holistic, whole‑cell assessment of quality at thaw, capturing vitality signatures that correlate strongly with:
- Expansion potential
- Transduction efficiency
- Vector productivity
- Stress tolerance
- Final product quality
These insights help teams select the strongest starting material, reduce variability, and improve outcomes across cell therapy, gene therapy, vaccine development, and other ATMP workflows.
Real‑Time Monitoring Improves Vitality & Viability in Continuous and Batch Bioprocessing
A recent LumaCyte technical note demonstrated how Radiance® enables real‑time monitoring of cell vitality and viability in both continuous and batch bioprocessing. Radiance® detected stress‑related changes earlier than traditional assays, giving teams the opportunity to intervene before cell health declined.
Key findings included:
- Earlier detection of vitality loss under process stress
- Improved decision‑making during continuous culture
- Enhanced consistency in batch processes
- Stronger alignment between early vitality signatures and final yield
These results show how real‑time, whole‑cell analytics strengthen process control and support more reliable outcomes across advanced biologics manufacturing.
Strengthening Quality Across Advanced Modalities
Vitality analytics are foundational across multiple ATMP and advanced biologics applications:
- Gene therapy: assessing producer cell fitness, transduction readiness, and vector productivity
- Cell therapy: evaluating donor variability, expansion potential, and functional robustness
- Vaccine development: monitoring cell health under production stress
- Biomanufacturing: improving consistency through early detection of functional decline
- Viral vector production: evaluating producer cell health, infection/transfection readiness, and functional signatures that correlate with vector yield, quality, and manufacturing consistency
Radiance® provides a unified, label‑free platform for evaluating cell quality across these diverse modalities, enabling teams to build stronger, more predictable processes from the very beginning.
A More Confident Path Forward
Cell quality determines the trajectory of every downstream step. With Radiance®, developers gain the clarity, speed, and predictive insight needed to ensure their cells are not just alive — but capable, resilient, and ready for manufacturing.
Radiance® helps teams move faster, reduce variability, and build higher‑quality advanced biologics and ATMPs, beginning with the most fundamental element: the cell.
